These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5318945)

  • 21. URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
    BOZZI R; BRUNO A; ALLEGRANZA A
    Br J Psychiatry; 1965 Feb; 111():176-82. PubMed ID: 14270530
    [No Abstract]   [Full Text] [Related]  

  • 22. The excretion of 5-hydroxyindoleacetic acid in normal and vascular deficient human subjects.
    Zawrocka-Wrzolkowa T
    Bull Acad Pol Sci Biol; 1965; 13(10):619-21. PubMed ID: 5887195
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of 5-hydroxytryptamine penetration through the cerebrospinal fluid-brain barrier.
    Bulat M; Supek Z
    Nature; 1968 Jul; 219(5149):72-3. PubMed ID: 5659622
    [No Abstract]   [Full Text] [Related]  

  • 24. Relation between brain 5-HIAA levels and the release of serotonin into brain synapses.
    Reinhard JF; Wurtman RJ
    Life Sci; 1977 Dec; 21(12):1741-6. PubMed ID: 604702
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of alpha-adrenolytics on the levels of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in rat's brain.
    Zebrowska-Lupina I; Kleinrok Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):241-5. PubMed ID: 1713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and metabolism of [14C] serotonin in rat brain.
    Palaić D; Page IH; Khairallah PA
    J Neurochem; 1967 Jan; 14(1):63-9. PubMed ID: 6018081
    [No Abstract]   [Full Text] [Related]  

  • 27. In vivo measurements by differential pulse voltammetry of extra-cellular 5-hydroxyindoleacetic acid in the rat brain.
    Cespuglio R; Faradji H; Ponchon JL; Riou F; Buda M; Gonon F; Pujol JF; Jouvet M
    J Physiol (Paris); 1981; 77(2-3):327-32. PubMed ID: 6169830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine.
    Curzon G; Theaker P; Phillips B
    J Neurol Neurosurg Psychiatry; 1966 Feb; 29(1):85-90. PubMed ID: 5910583
    [No Abstract]   [Full Text] [Related]  

  • 29. The metabolism of 5-hydroxytryptamine by blood platelets from children with mongolism.
    Boullin DJ; O'Brien RA
    Biochem Pharmacol; 1973 Jul; 22(13):1647-51. PubMed ID: 4269711
    [No Abstract]   [Full Text] [Related]  

  • 30. [Excretion of 5-hydroxy-indole-acetic acid in various mental disorders].
    MARIANI E; REDA G; MONTANARI F
    Riv Neurol; 1960; 30():195-203. PubMed ID: 13766721
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differential diagnostic considerations in increased 5-hydroxyindoleacetic acid excretion in the urine].
    KIRBERGER E
    Dtsch Med Wochenschr; 1962 May; 87():929-34. PubMed ID: 14456234
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain serotonin metabolism with relation to the head twitches elicited by lithium in combination with reserpine in mice.
    Furukawa T; Yamada K; Kohno Y; Nagasaki N
    Pharmacol Biochem Behav; 1979 Apr; 10(4):547-9. PubMed ID: 156925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RESERPINE TOLERANCE TEST IN SCHIZOPHRENIC SUBJECTS.
    BRUNO A; ALLERGRANZA A; BOZZI R
    J Nerv Ment Dis; 1964 Sep; 139():241-6. PubMed ID: 14212176
    [No Abstract]   [Full Text] [Related]  

  • 34. Variations of urinary creatinine and its correlation to excretion of indole metabolites in mental patients.
    Pscheidt GR; Berlet HH; Spaide J; Himwich HE
    Clin Chim Acta; 1966 Feb; 13(2):228-34. PubMed ID: 5941740
    [No Abstract]   [Full Text] [Related]  

  • 35. Enhancement of 5-hydroxytryptamine synthesis in brain by monamine-depleting drugs.
    Saner A; Pletscher A
    J Pharm Pharmacol; 1978 Feb; 30(2):115-7. PubMed ID: 24096
    [No Abstract]   [Full Text] [Related]  

  • 36. [STUDY OF THE URINARY EXCRETION OF ENDOGENOUS 5-HYDROXYINDOLACETIC ACID IN MANIC-DEPRESSIVE PSYCHOSIS].
    ENKIN M; BECACHE A; REVOL L
    Encephale; 1963; 52():321-65. PubMed ID: 14079280
    [No Abstract]   [Full Text] [Related]  

  • 37. [STUDIES OF THE URINARY 5-HYDROXYINDOLEACETIC ACID WITH SPECIAL REFERENCE TO CASES WITH THYROID DISORDERS].
    CHIBA N
    Tohoku Igaku Zasshi; 1963 May; 67():543-61. PubMed ID: 14159772
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in monoamine metabolites in the nucleus accumbens and locomotor activity by reserpine: an in vivo microdialysis study].
    Sugita R; Sawa Y; Nakazawa T; Yamauchi T
    Yakubutsu Seishin Kodo; 1988 Dec; 8(4):453-62. PubMed ID: 2471372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of body weight as a predictor of reserpine-induced amine depletion.
    Halaris AE; Freedman DX
    Eur J Pharmacol; 1975 May; 32(1):93-101. PubMed ID: 1149830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Excretion of 5-hydroxyindolic acid in the 24-hour urine in patients with stomach and duodenal ulcers].
    Pokora J; Czarnecki J
    Pol Tyg Lek; 1966 Mar; 21(13):462-3. PubMed ID: 5942387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.